This article summarises the key lessons from our webinar 'Delayed Diagnosis in Gynaecological Cancer: Breach, Causation and Missed Opportunities', with Mr Moiad Alazzam, Consultant Gynaecologist and Gynaecological Oncology Surgeon, who shared medico-legal insights from years of specialist practice in ovarian, endometrial, cervical, and vulval cancer. Below, we highlight the common pitfalls, red flags, and solicitor-focused takeaways.

Watch the full webinar with Mr Moiad Alazzam here ›

Referral Pathways & the Two‑Week Wait

• Presentation ≠ diagnosis: patients arrive with symptoms (bleeding, discharge, pain, abdominal changes). The first clinician must take a targeted history (incl. family history, meds like tamoxifen, and risk factors such as high BMI/PCOS), examine appropriately, and order the correct tests.

• Triaging: When red flags exist, referrals should be marked “suspected cancer (2WW)”, not merely “urgent.” In practice, an “urgent” routine slot may be months away; mis‑labelling can cause material harm.

• Follow‑up systems: Test results (imaging, bloods, cytology) must be seen, actioned, and communicated. Where uncertainty remains, use watch‑and‑wait with safety‑netting (clear return instructions, red flags, and time‑bound review).

⚠️ Key insight: Mis-labelling referrals as “urgent” instead of “suspected cancer (2WW)” creates months of delay and exposes practitioners to liability.

👉 For solicitors: Always check referral coding, was the pathway flagged correctly, and if not, did the delay cause harm?

Delay vs Negligent Delay

• Acceptable (non‑negligent) delay: Slippage within system constraints where assessment and safety‑netting meet professional standards.

• Negligent delay: Departure from accepted practice (e.g., failing to examine a bleeding cervix; not acting on a radiology “refer to gynae” comment; sending a high‑risk case down a routine pathway). Consider the impacts beyond “stage shift,” such as loss of optimal surgery (volume/residual disease shift), increased treatment burden, and psychological harm.

👉 For solicitors: Claims are strengthened where you can show not just a missed “stage shift” but harm through volume shift, loss of optimal surgery, or increased treatment burden.

Cancer‑Specific Pitfalls for Case Analysis

Ovarian / Fallopian Tube

• Non‑specific symptoms (bloating, weight change, constipation) are often misattributed.
• Complex cysts require age/menopausal status‑aware interpretation and appropriate scoring; distinguish benign/borderline/malignant and avoid tunnel‑vision.
• Material harm without stage shift: Delays can convert a potentially complete cytoreduction to sub‑optimal debulking (higher residual disease), worsening prognosis and morbidity.

👉 Solicitors: Focus on whether delayed referral reduced chances of optimal cytoreduction.

Endometrium (Uterine)

• The commonest gynae cancer in the West, strongly associated with obesity and anovulation/PCOS.
• Perimenopausal bleeding is a recurrent trap: do not assume “functional” causes; about one‑fifth of endometrial cancers occur pre‑menopause.
• Tamoxifen: anti‑oestrogen on the breast but partial agonist in the uterus; endometrial thickness thresholds are unreliable - manage by symptoms + risk profile, not thickness alone.
• Admin gaps kill: missed radiology recommendations, untracked results, and failure to phone DNA patients can be causative.

👉 Solicitors: Look for missed opportunities to act on risk factors and abnormal bleeding.

Cervix

• Abnormal bleeding + visible lesion demands urgent colposcopy/cancer pathway.
• Litigation frequently stems from cytology misreads or failure to examine; downstream consequences include loss of fertility (chemo‑radiation), fistulae, and stoma.

👉 Solicitors: These are common negligence hotspots with high evidential weight.

Vulva

• Two cohorts: HPV‑related and lichen sclerosus-related. Chronic itch, persistent lesions, or non‑healing areas warrant early biopsy.

👉 Solicitors: Missed biopsies can form the basis of clear breach arguments.

Case Examples & Outcomes (Patterns to Spot)

• Missed upgrade to 2WW: GP/radiology recommended gynae review but referral sent as routine → months lost → emergency presentation.
• Result not actioned: Ultrasound/CT flags thickened endometrium or pelvic mass; report sits unreviewed; no safety‑net → progression.
• MDT mis‑triage: Downgrading suspected sarcoma to benign fibroid without specialist input; no follow‑up imaging; surgery delayed; fatal outcome.
• Cervical lesion not examined: Managed as benign despite bleeding → later cancer with escalated treatment burden.

Key Takeaways for Solicitors

• Distinguishing negligent vs. non-negligent delay
  Not every diagnostic delay amounts to negligence, but where standards fall below accepted practice and lead to harm, claims are strengthened.
  👉 For solicitors: strengthens arguments around breach and causation - you’ll need to assess if the delay shifted prognosis or resulted in tangible harm.
• Importance of safety netting
  Patients must be given red-flag warnings and follow-up plans when uncertainty exists; failure to do so can itself constitute negligence.
  👉 For solicitors: look closely at whether a clinician provided adequate safety netting. Absence of this often forms a clear breach of duty.
• Red flags in gynaecological cancers
  Symptoms such as abnormal bleeding, discharge, pain, or new bowel/bladder changes should always trigger urgent assessment or referral.
  👉 For solicitors: useful when reviewing medical records - if red flags were documented but ignored, you may have a strong negligence case.
• Ovarian cancer complexity
  Often diagnosed late due to vague symptoms and overlap with benign conditions. Even without stage shift, delayed diagnosis can lead to “volume shift” and suboptimal treatment.
  👉 For solicitors: helps build arguments where prognosis worsened due to lost opportunity for optimal surgery, even if staging technically remained the same.
• Endometrial cancer risk factors
  High BMI, PCOS, tamoxifen use, and post-menopausal bleeding are critical red flags.
  👉 For solicitors: check whether these risk factors were recognised and acted upon. If missed, it may evidence negligent delay in referral or investigation.
• Cervical cancer negligence hotspots
  Misread cytology, failure to act on abnormal bleeding with visible lesions, and inadequate examination are common failings.
  👉 For solicitors: highlights common points of failure in case law - missed smear interpretation or lack of examination often underpin successful claims.
• Cross-specialty referral risks
  Poor communication between gynae, colorectal, or other departments frequently causes harmful delays.
  👉 For solicitors: review whether responsibility for referral was handed off properly. Lack of clear follow-up is often where breaches occur.
• Solicitor strategy tip
  Experts stressed that claims are stronger when solicitors clearly define whether they are dealing with stage shift, prognostic impact, or serious incident evidence.
  👉 For solicitors: clarifying this early helps instructing experts provide more targeted, supportive opinions for your case.

Quote Highlights

“Not every delay is negligent - but poor safety‑netting and mis‑triage often are.”

“In ovarian cancer, delays may not change stage, yet they often change volume - and that can be just as damaging clinically and legally.”

“Perimenopausal bleeding is not a free pass: around one‑fifth of endometrial cancers occur before menopause; treat risk, not assumptions.”

Watch the full webinar here ›